Overview
Oxford Nanopore Technologies develops and sells nanopore sequencing products including the portable MinION, desktop GridION, and high-throughput PromethION for direct electronic analysis of DNA, RNA, proteins, and small molecules. These devices enable real-time, long-read sequencing applicable to pharmaceutical R&D in personalized medicine, cancer research, immune system analysis, and clinical diagnostics. The technology supports genome assembly, structural variation detection, and antibody therapy development with scalable, field-deployable solutions.
Frequently asked questions
- What sequencing platforms does Oxford Nanopore offer?
- Key products include MinION (portable USB device generating up to 10 Gb data), GridION X5 (desktop processing up to 100 Gb per run with five flow cells), and PromethION (high-throughput with 144,000 nanopores), plus VolTRAX for automated library preparation.
- What are the main applications in pharma and life sciences?
- Applications cover genome assembly, structural variation, haplotype phasing, RNA analysis, cancer research, infectious disease, personalized medicine, and immune repertoire sequencing for antibody therapies.
- Is Oxford Nanopore technology real-time and portable?
- Yes, it provides real-time analysis of native DNA/RNA with ultra-long reads using portable devices like MinION, suitable for field and lab use without specialized skills via automation partners.